Guardant Health, Inc. - Common Stock (GH)

Historical Holders from Q4 2018 to Q3 2025

Symbol
GH on Nasdaq
CUSIP
40131M109
Type / Class
Equity / Common Stock
Shares outstanding
124M
All holders as of June 30, 2025
Q2 2025
Total 13F shares, excl. options
124M
Holdings value
$6.47B
% of all portfolios
0.01%
Grand Portfolio weight change
+0.001%
Number of holders
358
Number of buys
192
Number of sells
-157
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.004%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Guardant Health, Inc. - Common Stock (GH)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.5% $396M 9.29M BlackRock, Inc. Mar 31, 2025
Deep Track Capital, LP 4.41% $232M 5.44M Deep Track Capital, LP Mar 31, 2025
CADIAN CAPITAL MANAGEMENT, LP 4.2% $222M 5.22M Cadian Capital Management, LP Dec 31, 2024
WELLINGTON MANAGEMENT GROUP LLP 3.9% $207M 4.85M Wellington Management Group LLP Dec 31, 2024

Institutional Holders of Guardant Health, Inc. - Common Stock (GH)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 1.52M $94.9M +$37.4M $62.48 37
2025 Q2 124M $6.47B +$331M $52.04 358
2025 Q1 118M $5.05B +$16.7M $42.60 336
2024 Q4 120M $3.65B -$117M $30.55 294
2024 Q3 123M $2.83B +$157M $22.94 271
2024 Q2 115M $3.32B +$214M $28.88 283
2024 Q1 110M $2.27B -$27.7M $20.63 254
2023 Q4 748K $20.3M +$1.51M $27.05 3
2023 Q3 105M $3.11B -$95.1M $29.64 284
2023 Q2 107M $3.82B +$675M $35.80 287
2023 Q1 90.3M $2.12B +$62.5M $23.44 268
2022 Q4 92.1M $2.5B -$169M $27.20 277
2022 Q3 93.3M $5.02B +$80M $53.83 302
2022 Q2 92.2M $3.71B -$52.4M $40.34 305
2022 Q1 90.1M $5.95B -$87M $66.24 322
2021 Q4 91.8M $9.18B -$247M $100.02 371
2021 Q3 92.7M $11.6B +$573M $125.01 365
2021 Q2 89.4M $11.1B -$287M $124.19 407
2021 Q1 89.2M $13.6B +$676M $152.65 402
2020 Q4 85.7M $11.1B +$166M $128.88 389
2020 Q3 85M $9.5B +$181M $111.78 332
2020 Q2 82.7M $6.71B +$523M $81.13 302
2020 Q1 76.9M $5.35B +$251M $69.60 276
2019 Q4 76.9M $6.01B +$250M $78.14 254
2019 Q3 73.8M $4.71B -$155M $63.83 225
2019 Q2 75.8M $6.55B +$1.4B $86.33 210
2019 Q1 60.2M $4.62B +$11.8M $76.70 142
2018 Q4 61.7M $2.32B +$2.05B $37.59 86